Literature DB >> 11846908

Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery.

R J Bohinski1, R E Warnick, M F Gaskill-Shipley, M Zuccarello, H R van Loveren, D W Kormos, J M Tew.   

Abstract

OBJECTIVE: Well-established surgical goals for pituitary macroadenomas include gross total resection for noninvasive tumors and debulking with optic chiasm decompression for invasive tumors. In this report, we examine the safety, reliability, and outcome of intraoperative magnetic resonance imaging (iMRI) used to assess the extent of resection, and thus the achievement of preoperative surgical goals, during transsphenoidal microneurosurgery.
METHODS: Our magnetic resonance operating room contains a Hitachi AIRIS II 0.3-T, vertical-field open magnet (Hitachi Medical Systems America, Inc., Twinsburg, OH). A motorized scanner tabletop moves the patient between the imaging and operative positions. For transsphenoidal surgery, the patient is positioned directly on the scanner tabletop so that the surgical field is located between 1.2 and 1.6 m from the magnet isocenter. At this location, the magnetic field strength is low (<20 G), thus permitting the use of many conventional surgical instruments. Thirty consecutive patients with pituitary macroadenomas underwent tumor resection in our magnetic resonance operating room by use of a standard transsphenoidal approach. After initial resection, the patient was advanced into the scanner for imaging. If residual tumor was demonstrated and deemed surgically accessible, the patient underwent immediate re-exploration.
RESULTS: iMRI was performed successfully in all 30 patients. In one patient, iMRI was used to clarify the significance of hemorrhage from the sellar region and resulted in immediate conversion of the procedure to a craniotomy. In the remaining 29 patients, initial iMRI demonstrated that the endpoint for extent of resection had been achieved in only 10 patients (34%) after an initial resection attempt, whereas 19 patients (66%) still had unacceptable residual tumor. All 19 of these latter patients underwent re-exploration. Ultimately, re-exploration resulted in the achievement of the planned endpoint for extent of resection in all of the 29 completed transsphenoidal explorations. Operative time was extended in all cases by at least 20 minutes.
CONCLUSION: iMRI can be used to safely, reliably, and objectively assess the extent of resection of pituitary macroadenomas during the transsphenoidal approach. The surgeon is frequently surprised by the extent of residual tumor after an initial resection attempt and finds the intraoperative images useful for guiding further resection.

Entities:  

Mesh:

Year:  2001        PMID: 11846908     DOI: 10.1097/00006123-200111000-00023

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  33 in total

Review 1.  Intraoperative magnetic resonance imaging assessment of non-functioning pituitary adenomas during transsphenoidal surgery.

Authors:  Kunal S Patel; Yong Yao; Renzhi Wang; Bob S Carter; Clark C Chen
Journal:  Pituitary       Date:  2016-04       Impact factor: 4.107

2.  Use of a compact intraoperative low-field magnetic imager in pediatric neurosurgery.

Authors:  Amer F Samdani; Michael Schulder; Jeffrey E Catrambone; Peter W Carmel
Journal:  Childs Nerv Syst       Date:  2004-11-25       Impact factor: 1.475

Review 3.  Treatment of pituitary tumors: surgery.

Authors:  Michael Buchfelder
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

4.  Endoscopic versus microscopic approach for surgical treatment of acromegaly.

Authors:  Hussein Fathalla; Michael D Cusimano; Antonio Di Ieva; John Lee; Omar Alsharif; Jeannette Goguen; Stanley Zhang; Harley Smyth
Journal:  Neurosurg Rev       Date:  2015-02-10       Impact factor: 3.042

5.  Utility of three-dimensional computed tomography for anatomical assistance in endoscopic endonasal transsphenoidal surgery.

Authors:  Akihiro Inoue; Takanori Ohnishi; Shohei Kohno; Hironobu Harada; Masahiro Nishikawa; Saya Ozaki; Shirabe Matsumoto; Shiro Ohue
Journal:  Neurosurg Rev       Date:  2015-04-07       Impact factor: 3.042

6.  Creating an Intraoperative MRI Suite for the Musculoskeletal Tumor Center.

Authors:  Nathan W Mesko; David M Joyce; Hakan Ilaslan; Michael J Joyce
Journal:  Clin Orthop Relat Res       Date:  2015-07-17       Impact factor: 4.176

7.  The current role of transcranial surgery in the management of pituitary adenomas.

Authors:  Ravindran Pratheesh; Simon Rajaratnam; Krishna Prabhu; Sunithi E Mani; Geeta Chacko; Ari G Chacko
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

Review 8.  Intraoperative magnetic resonance imaging during surgery for pituitary adenomas: pros and cons.

Authors:  Michael Buchfelder; Sven-Martin Schlaffer
Journal:  Endocrine       Date:  2012-07-26       Impact factor: 3.633

9.  Dual-room 1.5-T intraoperative magnetic resonance imaging suite with a movable magnet: implementation and preliminary experience.

Authors:  Xiaolei Chen; Bai-nan Xu; Xianghui Meng; Jun Zhang; Xingguang Yu; Dingbiao Zhou
Journal:  Neurosurg Rev       Date:  2011-06-15       Impact factor: 3.042

10.  Transsphenoidal resection of sellar tumors using high-field intraoperative magnetic resonance imaging.

Authors:  Nicholas J Szerlip; Yi-Chen Zhang; Dimitris G Placantonakis; Marc Goldman; Kara B Colevas; David G Rubin; Eric J Kobylarz; Sasan Karimi; Monica Girotra; Viviane Tabar
Journal:  Skull Base       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.